RESUMO
AIM AND BACKGROUND: Malignant pleural mesothelioma (MPM) is a lethal cancer mainly caused by chronic exposure of asbestos. In this pilot study, we aimed to assess the expression of serum RNA-based biomarker panel exploring their clinical utility as diagnostic and prognostic biomarkers for MPM. METHODS: We have selected an MPM-specific RNA-based biomarker panel through bioinformatics analysis based on the integration of DNA damage regulated autophagy modulator 1 (DRAM1) and arylsulfatase A ( ARSA) gene expression with their epigenetic regulators microRNA ( miR-2053) and long noncoding RNA ( lncRNA-RP1-86D1.3). Then, quantitative real-time polymerase chain reaction (qPCR) validation in sera of 60 MPM patients, 20 chronic asbestos exposure patients, and 20 healthy volunteers was done. Lastly, the prognostic power of the selected panel was assessed. RESULTS: The expression of serum DRAM1 messenger RNA (mRNA), ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 were positive in 78.3%, 90%, 85%, and 83.3% of MPM patients, respectively. The RNA-based biomarker panel was able to discriminate between MPM patients and controls with high accuracy and their combined sensitivity reached 100% for the diagnosis of MPM. Kaplan-Meier analysis showed that hsa-miR-2053 is an independent prognostic factor of MPM. CONCLUSION: Our preliminary data revealed that the chosen RNAs play an important role in driving MPM development and progression.
Assuntos
Cerebrosídeo Sulfatase/sangue , Neoplasias Pulmonares/sangue , Proteínas de Membrana/sangue , Mesotelioma/sangue , MicroRNAs/sangue , Neoplasias Pleurais/sangue , RNA Longo não Codificante/sangue , Feminino , Regulação Neoplásica da Expressão Gênica/genética , Humanos , Modelos Lineares , Masculino , Mesotelioma Maligno , Reação em Cadeia da Polimerase em Tempo RealRESUMO
In metachromatic leukodystrophy (MLD), the deficiency of the lysosomal enzyme arylsulfatase A (ARSA) leads to demyelination in the central and peripheral nervous system and ultimately to death. Allogeneic hematopoietic SCT (HSCT) is currently the only treatment for adult and late-onset juvenile MLD, although it is still in question because of insufficient follow-up. We wanted to determine whether HSCT could halt the progression of adult and late-onset juvenile MLD. Four treated unrelated patients and three untreated siblings were included in the study, and followed regularly for up to 18 years after transplantation. The patients were assessed from clinical examination, ARSA enzyme levels, magnetic resonance imaging of the brain and neuropsychological and neurophysiological tests. In the treated patients, ARSA levels were normal up to 18 years after transplantation. The parameters evaluated stabilized and remained stable after a latency period of 12-24 months. Two patients live normal lives, partially in a protected environment. The other two patients stabilized at a low cognitive and functional level. One of the controls is demented, one is in a vegetative state and one died. We conclude that, in comparison with their untreated siblings, HSCT halted the progression of the disease in our treated patients.
Assuntos
Cerebrosídeo Sulfatase/sangue , Transplante de Células-Tronco Hematopoéticas , Leucodistrofia Metacromática/sangue , Leucodistrofia Metacromática/diagnóstico por imagem , Leucodistrofia Metacromática/terapia , Imageamento por Ressonância Magnética , Adolescente , Adulto , Aloenxertos , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Radiografia , Fatores de TempoRESUMO
Haematopoietic stem cell transplantation has an unproven role in the management of late-onset metachromatic leukodystrophy: theoretically justified through the engraftment of enzyme-replete haematopoietic progenitors and restoration of capacity for sulphatide catabolism in neural tissue through enzyme recapture, the long-term outcome is unknown. The rarity of the psycho-cognitive variant and slow progression of late-onset disease impairs evaluation of treatment. We report detailed clinical and neuropsychological assessments after haematopoietic stem-cell transplantation in a patient with a late-onset psycho-cognitive form of metachromatic leukodystrophy. Cognitive decline, indistinguishable from the natural course of the disease, was serially documented over 11 years despite complete donor chimaerism and correction of leukocyte arylsulphatase A to wild type values; subtle motor deterioration was similarly noted and progressive cerebral volume loss was evident upon magnetic resonance imaging. Sensory nerve conduction deteriorated 17 months post-transplantation with apparent stabilisation at 11-year review. Haematopoietic stem-cell transplantation was ineffective for this rare attenuated variant of metachromatic leukodystrophy. In the few patients identified pre-symptomatically or with early-phase disease, clear recommendations are lacking; when transplantation is considered, umbilical cord blood grafts from enzyme-replete donors with adjunctive mesenchymal stem cell infusions from the same source may be preferable. Improved outcomes will depend on enhanced awareness and early diagnosis of the disease, so that promising interventions such as genetically modified, autologous stem cell transplantation have the best opportunity of success.
Assuntos
Transtornos Cognitivos/etiologia , Cognição , Transplante de Células-Tronco Hematopoéticas , Leucodistrofia Metacromática/cirurgia , Adulto , Idade de Início , Cerebrosídeo Sulfatase/sangue , Cerebrosídeo Sulfatase/deficiência , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/enzimologia , Transtornos Cognitivos/fisiopatologia , Transtornos Cognitivos/psicologia , Progressão da Doença , Feminino , Humanos , Leucócitos/enzimologia , Leucodistrofia Metacromática/complicações , Leucodistrofia Metacromática/diagnóstico , Leucodistrofia Metacromática/enzimologia , Leucodistrofia Metacromática/fisiopatologia , Leucodistrofia Metacromática/psicologia , Imageamento por Ressonância Magnética , Condução Nervosa , Exame Neurológico , Testes Neuropsicológicos , Fatores de Tempo , Falha de Tratamento , Adulto JovemRESUMO
El monóxido de carbono es considerado uno de los mayores contaminantes de la atmósfera terrestre. Sus principales fuentes productoras responsables de aproximadamente 80 por ciento de las emisiones, son los vehículos automotores que utilizan como combustible gasolina o diesel y los procesos industriales que utilizan compuestos del carbono. Esta sustancia es bien conocida por su toxicidad para el ser humano. Sus efectos tóxicos agudos incluida la muerte han sido estudiados ampliamente; sin embargo, sus potenciales efectos adversos a largo plazo son poco conocidos. En los últimos años, los estudios de investigación experimentales en animales y epidemiológicos en humanos han evidenciado relación entre población expuesta en forma crónica a niveles medios y bajos de monóxido de carbono en aire respirable y la aparición de efectos adversos en la salud humana especialmente en órganos de alto consumo de oxígeno como cerebro y corazón. Se han documentado efectos nocivos cardiovasculares y neuropsicológicos en presencia de concentraciones de monóxido de carbono en aire inferiores a 25 partes por millón y a niveles de carboxihemoglobina en sangre inferiores a 10 por ciento. Las alteraciones cardiovasculares que se han descrito son hipertensión arterial, aparición de arritmias y signos electrocardiográficos de isquemia. Déficit en memoria, atención, concentración y alteraciones del movimiento tipo parkinsonismo, son los cambios neuropsicológicos con mayor frecuencia asociados a exposición crónica a bajos niveles de monóxido de carbono y carboxihemoglobina.
Carbon monoxide is considered to be a major factor contaminating earths atmosphere. The main sources producing this contamination are cars using gasoline or diesel fuel and industrial processes using carbon compounds; these two are responsible for 80 percent of carbon monoxide being emitted to the atmosphere. This substance has a well-known toxic effect on human beings and its acute poisonous effects (including death) have been widely studied; however, its long-term chronic effects are still not known. During the last few years, experimental research on animals and studies of human epidemiology have established the relationship between chronic exposure to low and middle levels of carbon monoxide in breathable air and adverse effects on human health, especially on organs consuming large amounts of oxygen such as the heart and brain. Harmful cardiovascular and neuropsychological effects have been documented in carbon monoxide concentration in air of less than 25 ppm and in carboxyhaemoglobin levels in blood of less than 10 percent. The main cardiac damage described to date has been high blood pressure, cardiac arrhythm and electrocardiograph signs of ischemia. Lack of memory, attention, concentration and Parkinson-type altered movement are the neuropsychological changes most frequently associated with chronic exposure to low levels of carbon monoxide and carboxyhaemoglobin.
Assuntos
Adulto , Criança , Feminino , Humanos , Masculino , Poluentes Atmosféricos/análise , Monóxido de Carbono/análise , Arritmias Cardíacas , Hipóxia , Poluentes Atmosféricos/efeitos adversos , Biomarcadores , Química Encefálica/efeitos dos fármacos , Testes Respiratórios , Intoxicação por Monóxido de Carbono/etiologia , Intoxicação por Monóxido de Carbono/psicologia , Monóxido de Carbono/efeitos adversos , Monóxido de Carbono/farmacologia , Carboxihemoglobina/análise , Cerebrosídeo Sulfatase/sangue , Transtornos Cognitivos/epidemiologia , Transtornos Cognitivos/etiologia , Monitoramento Ambiental , Combustíveis Fósseis , Calefação , Hipertensão/epidemiologia , Hipertensão/etiologia , Resíduos Industriais/efeitos adversos , Resíduos Industriais/análise , América Latina/epidemiologia , Peroxidação de Lipídeos , Transtornos dos Movimentos/epidemiologia , Transtornos dos Movimentos/etiologia , Isquemia Miocárdica/epidemiologia , Isquemia Miocárdica/etiologia , Especificidade de Órgãos , Consumo de Oxigênio , Emissões de Veículos/efeitos adversos , Emissões de Veículos/análiseRESUMO
OBJECTIVES: This study was planned to evaluate the feasibility of the assay of leukocyte arylsulfatase-A (AS-A) activity, and some urinary cytokine levels (tumor necrosis factor-alpha [TNF-alpha] and interleukin-8 [IL-8]), as noninvasive diagnostic tools in different stages of bladder cancer patients. DESIGN AND METHODS: Blood and urine samples of 79 subjects were analyzed, including 28 healthy volunteers, 27 patients with superficial bladder cancer (SBC), and 24 patients with muscle invasive bladder cancer (MIBC). RESULTS: In SBC patients, the mean leukocyte AS-A activity was slightly higher (11.4%) than healthy subjects without reaching statistical significance. On the other hand, the enzyme activity in MIBC patients was significantly higher than those of controls (38.9%) and SBC patients (18.3%). Urinary TNF-alpha levels in both cancer groups were not significantly different from the control group. Urinary IL-8 levels of MIBC patients were significantly increased when compared with the levels of SBC patients and healthy subjects (P < 0.001). CONCLUSIONS: Based on our results, it may be concluded that measurement of leukocyte AS-A activity is not a sufficiently reliable noninvasive diagnostic test in distinguishing early stage bladder cancer from healthy subjects as well as detecting disease progression. Whereas measurement of urinary IL-8 may be valuable as a noninvasive diagnostic and prognostic test especially in patients with advanced bladder cancer. It also appears that complementary biochemical information may be obtained about the prognosis of the disease by monitoring urinary IL-8 profile. However, further confirmatory clinical trials about the prognostic value of the measurement of urinary IL-8 are needed.
Assuntos
Cerebrosídeo Sulfatase/sangue , Interleucina-8/urina , Fator de Necrose Tumoral alfa/urina , Neoplasias da Bexiga Urinária/sangue , Neoplasias da Bexiga Urinária/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Humanos , Interleucina-8/metabolismo , Leucócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Prognóstico , Curva ROC , Sensibilidade e EspecificidadeRESUMO
The possibility of using umbilical cord blood for transplantation in several enzyme deficiencies has received increasing attention because of the availability of cord blood, the reduced incidence of post-transplantation complications, such as graft-versus-host disease and the possible accomplishment of good corrective results following transplantation, even in cases of greater HLA disparity. The use of hematopoietic stem cells from unrelated donors is even more highly recommended for the treatment of inherited enzyme deficiencies, because it might reduce the risk of the transplanted cells originating from a carrier of the defect, which might have an inadequate corrective ability. Our study was designed to elucidate whether the gestational age and mode of delivery influences the arylsulfatase-A activity in the umbilical cord blood. Enzyme activities proved to be similar in the four populations studied (full-term normal spontaneous vaginal delivery, full-term caesarean section, preterm normal spontaneous vaginal delivery and preterm caesarean section). Therefore, umbilical cord blood samples seem to be suitable for transplantation in metachromatic leukodystrophy, regardless of gestational age and mode of delivery. Moreover, our results are the first published data on normal values for arylsulfatase-A activity in human umbilical cord blood.
Assuntos
Cerebrosídeo Sulfatase/sangue , Parto Obstétrico/métodos , Sangue Fetal/enzimologia , Idade Gestacional , Cesárea/métodos , Ativação Enzimática/fisiologia , Feminino , Transplante de Células-Tronco Hematopoéticas/métodos , Humanos , Recém-Nascido , Criança Pós-Termo/sangue , Recém-Nascido Prematuro/sangue , Leucodistrofia Metacromática/cirurgia , Gravidez , Segundo Trimestre da Gravidez/sangue , Terceiro Trimestre da Gravidez/sangue , Terceiro Trimestre da Gravidez/metabolismo , Transplante de Células-Tronco , Células-Tronco/enzimologiaRESUMO
Arylsulfatase A (ASA) knockout mice represent an animal model for the lysosomal storage disease metachromatic leukodystrophy (MLD). Stem cell gene therapy with bone marrow overexpressing the human ASA cDNA from a retroviral vector resulted in the expression of high enzyme levels in various tissues. Treatment partially reduces sulfatide storage in livers exceeding 18 ng ASA/mg tissue, while complete reduction was observed in livers exceeding 50 ng ASA/mg tissue. This corresponds to about 80% and 200% of normal enzyme activity. Similar values seem to apply for kidney. A partial correction of the lipid metabolism was detectable in the brain where the galactoerebroside/sulfatide ratio, which is diminished in ASA-deficient mice, increased upon treatment. This partial correction was accompanied by amelioration of neuropathology; axonal cross-sectional areas, which are reduced in deficient mice, were significantly increased in the saphenic and sciatic nerve but not in the optic nerve. Behavioral tests suggest some improvement of neuromotor abilities. The gene transfer did not delay the degeneration occurring in the acoustic ganglion of ASA-deficient animals. The limited success of the therapy appears to be due to the requirement of unexpected high levels of ASA for correction of the metabolic defect.
Assuntos
Cerebrosídeo Sulfatase/genética , Terapia Genética/métodos , Transplante de Células-Tronco Hematopoéticas , Leucodistrofia Metacromática/terapia , Animais , Anticorpos/sangue , Comportamento Animal , Encéfalo/metabolismo , Sistema Nervoso Central/metabolismo , Cerebrosídeo Sulfatase/sangue , Cerebrosídeo Sulfatase/imunologia , Feminino , Vetores Genéticos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Knockout , Modelos Animais , Retroviridae/genética , Sulfoglicoesfingolipídeos/metabolismo , Transdução GenéticaRESUMO
This study was designed to evaluate the effect of different conditions of collection, transport and storage on the quality of blood samples from normal individuals in terms of the activity of the enzymes Beta-glucuronidase, total hexosaminidase, hexosaminidase A, arylsulfatase A and Beta-galactosidase. The enzyme activities were not affected by the different materials used for collection (plastic syringes or vacuum glass tubes). In the evaluation of different heparin concentrations (10 percent heparin, 5 percent heparin, and heparinized syringe) in the syringes, it was observed that higher doses resulted in an increase of at least 1-fold in the activities of Beta-galactosidase, total hexosaminidase and hexosaminidase A in leukocytes, and Beta-glucuronidase in plasma. When the effects of time and means of transportation were studied, samples that had been kept at room temperature showed higher deterioration with time (72 and 96 h) before processing, and in this case it was impossible to isolate leukocytes from most samples. Comparison of heparin and acid citrate-dextrose (ACD) as anticoagulants revealed that Beta-glucuronidase and hexosaminidase activities in plasma reached levels near the lower normal limits when ACD was used. In conclusion, we observed that heparin should be used as the preferable anticoagulant when measuring these lysosomal enzyme activities, and we recommend that, when transport time is more than 24 h, samples should be shipped by air in a styrofoam box containing wet ice
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Adolescente , Coleta de Amostras Sanguíneas , Cerebrosídeo Sulfatase/sangue , Glicosídeo Hidrolases/sangue , Leucócitos/enzimologia , Lisossomos/enzimologia , Anticoagulantes/farmacologia , beta-Galactosidase/sangue , beta-N-Acetil-Hexosaminidases/sangue , Coleta de Amostras Sanguíneas/métodos , Ácido Cítrico/farmacologia , Heparina/farmacologiaRESUMO
Umbilical cord blood (UCB) has received increasing attention as a source of unrelated hematopoietic stem cells for transplantation. Lysosomal diseases have been effectively treated and normal enzymatic activity has occurred subsequent to engraftment using UCB. The use of donor cells with normal amounts of enzyme, rather than those from carriers whose level may be 50% or less, is an obvious goal. The frequency of such heterozygotes varies from 1:10 to 1:140 or lower depending upon the disease at issue. We assayed the levels of lysosomal enzymes in normal UCB in random samples as well as those used for transplantation. We measured the following enzymatic activities: alpha-l-iduronidase (Hurler), galactocerebrosidase (globoid cell leuko- dystrophy) and arylsulfatase A (metachromatic leukodystrophy). For the latter, levels of activity in UCB are comparable to those found in adult blood. In the case of arylsulfatase B (Maroteaux-Lamy) a level lower than adult level was found. An informed choice by the transplanting physician based on the activity of the relevant enzyme in the UCB donor will provide a better opportunity for an improved prognosis for more complete correction of the recipient's primary disease. Bone Marrow Transplantation (2000) 25, 541-544.
Assuntos
Sangue Fetal/enzimologia , Lisossomos/enzimologia , Adulto , Cerebrosídeo Sulfatase/sangue , Cerebrosídeo Sulfatase/metabolismo , Estudos de Avaliação como Assunto , Galactosilceramidase/sangue , Galactosilceramidase/metabolismo , Humanos , Iduronidase/sangue , Iduronidase/metabolismo , Recém-Nascido , Cinética , Leucócitos/enzimologia , N-Acetilgalactosamina-4-Sulfatase/sangue , N-Acetilgalactosamina-4-Sulfatase/metabolismoRESUMO
We investigated the effects of vinyl chloride monomer exposure on the liver of 86 workers by measuring beta-glucuronidase, arylsulfatase A, adenosine deaminase, 5'-nucleotidase and routine liver function enzymes in the sera of the workers. In 21 of them, three or more of these parameters were raised, with a significant decrease in the level of blood glutathione and a significant increase in the enzyme activity level of glutathione S-transferase. Of these 21 workers, 14 had fatty liver infiltration, 8 of whom were also suffering from liver enlargement. Also, 4 workers had liver enlargement without fatty infiltration and 3 had enlarged spleens. The study highlights the need for vigilance in environmental monitoring and medical surveillance of workers exposed to this chemical.
Assuntos
Carcinógenos , Fígado Gorduroso/induzido quimicamente , Hepatomegalia/induzido quimicamente , Doenças Profissionais/induzido quimicamente , Exposição Ocupacional/efeitos adversos , Esplenomegalia/induzido quimicamente , Cloreto de Vinil/intoxicação , 5'-Nucleotidase/sangue , Adenosina Desaminase/sangue , Adulto , Estudos de Casos e Controles , Cerebrosídeo Sulfatase/sangue , Egito , Monitoramento Ambiental , Fígado Gorduroso/diagnóstico , Fígado Gorduroso/enzimologia , Fígado Gorduroso/prevenção & controle , Glucuronidase/sangue , Glutationa Transferase/sangue , Hepatomegalia/diagnóstico , Hepatomegalia/enzimologia , Hepatomegalia/prevenção & controle , Humanos , Testes de Função Hepática , Masculino , Avaliação das Necessidades , Doenças Profissionais/diagnóstico , Doenças Profissionais/enzimologia , Doenças Profissionais/prevenção & controle , Exposição Ocupacional/análise , Saúde Ocupacional , Esplenomegalia/diagnóstico , Esplenomegalia/enzimologia , Esplenomegalia/prevenção & controleRESUMO
The level of adenosine deaminase (ADA) and arylsulphatase A (ASA) in the sera of 22 patients with acute lymphoblastic leukemia (ALL) were significantly increased when compared with the control healthy group. Also, there is a significant increase in the activity of these enzymes in patients with ALL with central nervous system (CNS) infiltration when compared with patients of ALL without CNS infiltration. We conclude that the estimation of ADA and ASA in the serum may be useful for detection of the early infiltration of the central nervous system by leukemic cells in acute lymphoblastic leukemia.
Assuntos
Adenosina Desaminase/sangue , Biomarcadores Tumorais/sangue , Sistema Nervoso Central/patologia , Cerebrosídeo Sulfatase/sangue , Infiltração Leucêmica/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/sangue , Leucemia-Linfoma Linfoblástico de Células Precursoras/enzimologia , Adulto , HumanosRESUMO
A 28-year-old woman with a 4 year history of slowly progressing 'frontal dementia' was diagnosed as having adult metachromatic leukodystrophy and was followed for 4 years after bone marrow transplantation (BMT). MRI, neurophysiological tests (EEG, ENeG, VEP, SEP and BAEP) and neuropsychological assessment were performed before, and repeatedly after BMT. MRI showed symmetrical white matter lesions in the frontal and parieto-occipital lobes and in the corpus callosum. EEG showed frontal and temporal slow wave abnormalities and nerve conduction was slow. Neuropsychological tests showed cognitive impairment in executive functions, decline in visuospatial-constructive and spatial memory tasks and disorganized thinking. IQ was low (52), with slightly better values for verbal IQ than for performance IQ. After BMT, the patient was followed for 4 years. Clear improvements were seen in EEG, in peripheral nerve conduction and in neuropsychological tests (especially in verbal IQ). MRI findings were unchanged. We believe that the improvement in our patient resulted from the bone marrow transplantation.
Assuntos
Transplante de Medula Óssea , Inteligência , Leucodistrofia Metacromática/fisiopatologia , Leucodistrofia Metacromática/terapia , Nervos Periféricos/fisiopatologia , Adulto , Encéfalo/patologia , Cerebrosídeo Sulfatase/sangue , Cerebrosídeo Sulfatase/deficiência , Eletroencefalografia , Feminino , Humanos , Leucodistrofia Metacromática/psicologia , Imageamento por Ressonância Magnética , Condução Nervosa , Fatores de TempoRESUMO
La leucodistrofia metacromática (LDM) es una enfermedad degenerativa causada por la deficiencia de la enzima aril sulfatasa A (ASA), que puede cursar con síntomas psiquiátricos. El propósito de esta investigación fue determinar la prevalencia de la deficiencia de ASA en un grupo de 23 pacientes con esquizofrenia. El valor de la mediana del ASA sérica en ellos fue 53.2 nmol/mL/h (rango 3.3-152-5). Seis (26 por ciento) presentaban actividades baja del ASA sérica (< 27.5 nmol/mL/h que es el límite inferior observado en 29 controles normales). Cinco de ellos tenían historia clínica de delirio de grandez, alucinaciones auditivas, hospitalizaciones múltiples, respuesta pobre a los neurolépticos y potenciales evocados anormales. Es probable que los síntomas esquizofrénicos fueran secundarios a la deficiencia de la enzima. Los hallazgos de este estudio son de utilidad en la clínica ya que ASA puede ayudar a identificar casos de LDM en pacientes presumiblemente esquizofrénicos
Assuntos
Criança , Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Cerebrosídeo Sulfatase , Cerebrosídeo Sulfatase/sangue , Cerebrosídeo Sulfatase/urina , Leucodistrofia Metacromática/diagnóstico , Leucodistrofia Metacromática/fisiopatologia , Esquizofrenia/enzimologiaRESUMO
This study was planned to investigate whether the physiological variations in endogenous gonadal steroid hormones during fertile period to menopause might affect the Arylsulphatase A (ARS-A) activities in leukocytes in healthy women. In premenopausal women, means of the leukocyte ARS-A activity were significantly highest at ovulatory phase, and lowest at early follicular phase. In contrast, the mean leukocyte ARS-A activity in postmenopausal women was approximately equivalent to the mean leukocyte enzyme in cycling women at early follicular phase in whom the lowest enzymatic activity was observed. The results of our study, therefore, concluded that gonadal steroid released physiologically into the bloodstream might be expected to stimulate the lysosomal system thereby leading to an enhancement in leukocyte ARS-A activity.
Assuntos
Cerebrosídeo Sulfatase/sangue , Estradiol/sangue , Leucócitos/enzimologia , Pós-Menopausa/sangue , Progesterona/sangue , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-IdadeRESUMO
Lysosomal arylsulphatase A of peripheral leukocytes from patients with acute lymphoblastic and myeloblastic leukemia and from healthy subjects, were studied. Arylsulphatase A activity of both types of leukemic cells was significantly higher than those of cells from healthy subjects. From our present observations, it can be concluded that estimation of lysosomal arylsulphatase A of leukocytes, may be of value clinically as a biochemical assay which can serve to demonstrate the presence of malignancy.
Assuntos
Cerebrosídeo Sulfatase/sangue , Leucemia Mieloide Aguda/enzimologia , Leucócitos/enzimologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/enzimologia , Adolescente , Adulto , Idoso , Biomarcadores Tumorais/sangue , Feminino , Humanos , Leucemia Mieloide Aguda/diagnóstico , Lisossomos/enzimologia , Masculino , Pessoa de Meia-Idade , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnósticoRESUMO
Arylsulfatase A was radioimmunoassayed in serum specimens of 96 healthy volunteers and 368 patients with histopathologically confirmed cancer of gastrointestinal tract, breast, lung, central nervous system, kidney and woman genital tract. Sensitivity, specificity and predictive value of the test were 43%, 82% and 90%, respectively, which means that a positive test is significant for diagnosis of cancer regardless of its localization. More detailed statistical analysis of the results indicates that determination of the serum concentration of arylsulfatase A might be helpful in the diagnosis of lung (59% sensitivity, 82% specificity) and central nervous system cancer (60% sensitivity, 82% specificity). Further studies should also be continued in respect to renal and women genital tract cancers for which the results of the test, although promising, are at present not conclusive due to the small numbers of examined cases. Particularly, determination of serum arylsulfatase A in case of endometrial cancer seems to be of diagnostic value. Arylsulfatase A concentration in serum with a lower than 40% sensitivity of the test cannot be considered as a valuable tumor indicator in the case of cancer of breast and gastrointestinal tract, although 80% predictive value of the test for the latter group of tumors is quite high and perhaps merits additional consideration.
Assuntos
Cerebrosídeo Sulfatase/sangue , Neoplasias/enzimologia , Adulto , Neoplasias do Sistema Nervoso Central/enzimologia , Feminino , Neoplasias Gastrointestinais/enzimologia , Neoplasias dos Genitais Femininos/enzimologia , Humanos , Neoplasias Renais/enzimologia , Neoplasias Pulmonares/enzimologia , Masculino , Pessoa de Meia-Idade , Valores de Referência , Estatística como AssuntoAssuntos
Transplante de Medula Óssea , Leucodistrofia Metacromática/cirurgia , Fatores Etários , Cerebrosídeo Sulfatase/sangue , Criança , Feminino , Humanos , Leucócitos/enzimologia , Leucodistrofia Metacromática/metabolismo , Leucodistrofia Metacromática/fisiopatologia , Sulfoglicoesfingolipídeos/metabolismoRESUMO
Two fluorescent derivatives of cerebroside sulfate ('sulfatide') have been synthesized and used as substrates for determining arylsulfatase A activity. These were 12-(1-pyrene)dodecanoyl cerebroside sulfate (P12-sulfatide) and 12(1-pyrenesulfonylamido)dodecanoyl cerebroside sulfate (PSA12-sulfatide). When incubated at pH 5.0 in the presence of 5 mM MnCl2 and 5.5 mM of taurodeoxycholate, either substrate was hydrolyzed by arylsulfatase A of human leukocytes. The rate of hydrolysis was proportional to the incubation time and concentration of enzyme; Michaelis-Menten type kinetics were observed with increasing concentrations of substrate. For determining the rate of hydrolysis, each of the two products (i.e., P12- and PSA12-cerebrosides) were separated from the bulk of respective unreacted sulfatide on small columns of DEAE-Sephadex A-25 and their fluorescence intensities read at 343-378 and 350-380 nm for the excitation and emission wavelengths for P12- and PSA12-cerebrosides, respectively. When extracts of skin fibroblasts derived from normal individuals and patients with Maroteaux-Lamy (lacking arylsulfatase B) or metachromatic leukodystrophy (lacking arylsulfatase A) were used as source of enzyme, P12-sulfatide was hydrolyzed by the former two but not by the latter cell extract. Several derivatives of cerebroside sulfate were also synthesized and found to inhibit the hydrolysis of pyrenesulfatide by leukocyte arylsulfatase A. The results demonstrate that these two pyrene containing sulfatides can be effectively used as specific substrates for the determination of arylsulfatase A activity in extract of cells and most probably also of tissues.
Assuntos
Cerebrosídeo Sulfatase/sangue , Cerebrosídeos/síntese química , Leucócitos/enzimologia , Pirenos/síntese química , Sulfoglicoesfingolipídeos/síntese química , Animais , Bovinos , Cerebrosídeos/metabolismo , Corantes Fluorescentes , Humanos , Hidrólise , Cinética , Leucodistrofia Metacromática/enzimologia , Espectroscopia de Ressonância Magnética , Mucopolissacaridose VI/enzimologia , Pirenos/metabolismo , Espectrometria de Fluorescência , Espectrofotometria , Especificidade por Substrato , Sulfoglicoesfingolipídeos/metabolismoRESUMO
A total of 1728 patients consecutively admitted to a neuropsychiatric hospital and 379 chronically ill inpatients were examined for activity of arylsulphatase A (ASA) in leucocytes. A further 519 healthy individuals served as controls. We did not find evidence for the involvement of low ASA activity in chronic patients. The consecutive admissions showed a slight preponderance in the lower ASA activity classes. This activity range covers persons heterozygous for ASA deficiency alleles. The data are compatible with the hypothesis that carriers of low ASA activity alleles are at a slightly higher risk for neuropsychiatric disorders.